273221-97-9 Usage
Uses
Used in Organic Synthesis:
BOC-L-TRANSPRO(4-CH2OH) is used as a building block in organic synthesis for the creation of peptides and other complex molecules. Its presence of a BOC protective group and an ethyl ester group allows for versatile applications in the synthesis of various organic compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, BOC-L-TRANSPRO(4-CH2OH) is used as an intermediate in the synthesis of drugs and drug candidates. Its unique structure and functional groups make it a valuable component in the development of new therapeutic agents.
Used in Research and Development:
BOC-L-TRANSPRO(4-CH2OH) is utilized in research and development settings for the study of peptide synthesis, protein engineering, and the development of novel bioactive molecules. Its presence in these processes aids in understanding the structure-function relationships of peptides and proteins, as well as in the discovery of new bioactive compounds with potential therapeutic applications.
Used in Chemical Education:
BOC-L-TRANSPRO(4-CH2OH) is also used in chemical education to teach students about the synthesis of peptides, the use of protective groups in organic synthesis, and the properties of amino acid derivatives. It serves as a practical example of how complex organic molecules can be built from simpler building blocks.
Check Digit Verification of cas no
The CAS Registry Mumber 273221-97-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,3,2,2 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 273221-97:
(8*2)+(7*7)+(6*3)+(5*2)+(4*2)+(3*1)+(2*9)+(1*7)=129
129 % 10 = 9
So 273221-97-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H19NO5/c1-11(2,3)17-10(16)12-5-7(6-13)4-8(12)9(14)15/h7-8,13H,4-6H2,1-3H3,(H,14,15)/t7-,8+/m1/s1
273221-97-9Relevant academic research and scientific papers
Inhibitors of Hepatitis C Virus
-
Page/Page column 72, (2008/12/04)
Macrocyclic peptides are disclosed having the general formula: wherein R3, R3′, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Inhibitors of Hepatitis C Virus
-
Page/Page column 68, (2008/12/04)
Macrocyclic peptides are disclosed having the general formula: wherein R3, R3′, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Inhibitors of Hepatitis C Virus
-
Page/Page column 72, (2008/12/04)
Macrocyclic peptides are disclosed having the general formula: wherein R3, R′3, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Hepatitis C virus inhibitors
-
Page/Page column 73, (2010/11/26)
Macrocyclic peptides are disclosed having the general formula: wherein R′, R3, R3′, R4, R6, X, Q, and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
HEPATITIS C VIRUS INHIBITORS
-
Page 471-472, (2008/06/13)
Hepatitis C virus inhibitors are disclosed having the general formula:(I) wherein R1, R2, R3, R', B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds toinhibit HCV are also disclosed.
